Management of Type 1 diabetes mellitus with autologous mesenchymal stem cells

• Egile Nagusiak: Pradeep V Mahajan (Egilea), Aabha Morey (Egilea), Swetha Subramanian (Egilea), Anurag Bandre (Egilea), Harshal Ware (Egilea)
• Formatua: Liburua
• Argitaratua: Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Type 1 diabetes mellitus (DM) is one of the most common chronic metabolic disorders among children. The condition is associated with dysregulation of the immune system resulting in loss of self-tolerance and destruction of pancreatic β-cells by autoreactive T-lymphocytes. Regulation of β-cell homeos...